SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DJ who wrote (322)5/12/1999 3:57:00 PM
From: Roger Cranwill   of 656
 
The one I'm really hot on now is Imclone (IMCL). Its stock price has more than doubled since Feb, and appears to be about to "pop". If anyone isn't familiar with their lead product, a monoclonal antibody for head and neck squamous cell carcinoma, in Phase II trials of 16 patients tried on the drug 13 showed 100% regression (tumor gone, in other words)-the other 3 showed tumor regression of 50% or better.
Coulter Pharmaceutical (CLTR) is also beginning to climb-their radioisotope linked monoclonal antibody for Non-Hodgkins lymphoma should be ready for approval by the end of this year, or the beginning of next.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News